OpenAI CEO Sam Altman announced that the company is working with the U.S. Department of Defense (DoD) to update their existing agreement, reinforcing clear boundaries around how OpenAI’s technology, including ChatGPT, can be used. In a post shared on X (formerly Twitter), Altman stated that the revisions are designed to make the company’s principles “very clear” as its relationship with the Pentagon evolves.
According to Altman, one key addition to the agreement specifies that OpenAI’s services will not be used by U.S. intelligence agencies under the Department of Defense, such as the National Security Agency (NSA). He emphasized that any potential use of OpenAI technology by these intelligence entities would require a separate follow-on contract modification. This clarification aims to address public concerns about artificial intelligence deployment in sensitive national security operations.
The update follows OpenAI’s recent announcement that it will deploy its AI technology within the Defense Department’s classified network. The partnership marks a significant step in integrating advanced artificial intelligence tools into government systems while maintaining strict oversight and compliance with established ethical guidelines.
OpenAI has consistently stated that it prioritizes responsible AI development and transparency, especially when working with government agencies. By formally defining the scope of its agreement with the DoD, the company seeks to ensure its AI services are used in alignment with its published safety and usage policies.
As artificial intelligence adoption expands across federal agencies, this updated agreement highlights the growing intersection between AI innovation and national defense. It also underscores OpenAI’s effort to balance technological advancement with accountability, particularly in high-stakes environments such as defense and intelligence operations.


Meta, U.S. States Discuss Settlement in Teen Addiction Trial
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Nvidia Eyes Perplexity Investment at $30 Billion Valuation
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
New Zealand Labour Backs Social Media Ban for Under-16s
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints
Alibaba Raises $10.2 Billion to Expand AI Infrastructure
Unitree Shares Plunge 45% After Blockbuster IPO, Raising China Tech Bubble Fears
OpenAI AI Agent Swarm Behind Hugging Face Hack
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments
Amazon Secures 200 MW Wind Power Deals in Sweden
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Street Poller Media and The Boom of the Street Interview Ad Industry 



